Development
A company launches to bring germline correction stateside
Claim
Cathy Tie launched Origin Genomics to advance precision germline gene correction and mitochondrial replacement therapy in the United States.
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to March 20, 2026 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.